E
Biomerica, Inc. BMRA
$2.38 -$0.02-0.63% NASDAQ
Recommendation
Prev Close
$2.39
Volume
22,395
Avg Vol (90D)
100,219
Market Cap
$7.22M
Dividend & Yield
--
52-Week Range
$2.11 - $8.80
P/E (TTM)
--
EPS (TTM)
-$1.67
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Biomerica (NASDAQ:BMRA) Share Price Passes Below 200 Day Moving Average - Here's What Happened
1/30/2026 - Ticker Report
Biomerica (NASDAQ:BMRA) Share Price Crosses Below Two Hundred Day Moving Average - Time to Sell?
1/22/2026 - Ticker Report
Biomerica (NASDAQ:BMRA) Posts Quarterly Earnings Results
1/15/2026 - Ticker Report
Biomerica, Inc. (NASDAQ:BMRA) Short Interest Up 123.2% in December
1/15/2026 - Ticker Report
Biomerica, Inc. Q2 Loss Widens
1/14/2026 - Nasdaq News: Markets
Biomerica Reports Second Quarter Fiscal 2026 Financial Results
1/14/2026 - GuruFocus
Biomerica Reports Second Quarter Fiscal 2026 Financial Results
1/14/2026 - GuruFocus
Biomerica Reports Second Quarter Fiscal 2026 Financial Results
1/14/2026 - Globe Newswire
Biomerica announces CMS Medicare payment rate of $300 for IBS test
12/23/2025 - The Fly
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods IBS Test
12/23/2025 - Globe Newswire
Biomerica (BMRA) Gains Approval for Rapid Tests in Egypt
12/11/2025 - GuruFocus
Egyptian Drug Authority Authorizes Biomerica's Complete Screening Test Portfolio
12/11/2025 - GuruFocus
Biomerica's complete screening test portfolio authorized in Egypt
12/11/2025 - The Fly
Egyptian Drug Authority Authorizes Biomerica's Complete Screening Test Portfolio
12/11/2025 - Globe Newswire
Biomerica (BMRA) Showcases Innovative IBS Therapy in Biotherapeutics Quarterly
11/25/2025 - GuruFocus
Biomerica announces inFoods IBS product featured in Biotherapeutics Quarterly
11/25/2025 - The Fly
Biomerica's inFoods IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS
11/25/2025 - Globe Newswire
Biomerica (NASDAQ:BMRA) Stock Crosses Below 200-Day Moving Average - What's Next?
11/9/2025 - Ticker Report
Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand
11/6/2025 - GuruFocus
Biomerica expands CDMO services to meet growing market demand
11/6/2025 - The Fly
Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand
11/6/2025 - Globe Newswire
Is Henry Schein (HSIC) Signaling a Strategic Shift Toward Specialty Diagnostics With Its Latest Partnership?
10/23/2025 - Simply Wall St
Henry Schein (HSIC): Evaluating Valuation After New Biomerica Deal and Analyst Downgrade
10/18/2025 - Simply Wall St
Will Biomerica Deal Help Henry Schein (HSIC) Advance Its Diagnostic Distribution Ambitions?
10/16/2025 - Simply Wall St
Income Statement
Total Revenue (TTM)
$4.46M
EBITDA (TTM)
-$5.18M
EBIT (TTM)
-$5.27M
Net Income (TTM)
-$4.03M
Balance Sheet
Total Assets (Q)
$6.03M
Total Debt (Q)
$284.00K
Total Liabilities (Q)
$1.60M
Book Value Per Share (Q)
$1.50
Cash Flow
Cash from Operations (TTM)
-$2.97M
Cash from Investing (TTM)
-$4.00K
Cash from Financing (TTM)
$3.13M
Net Change in Cash (TTM)
$172.00K
Filings
Filing Date
Wednesday, January 14, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of Apr 13 and 17 (est)
Price History
Loading...
Beta
1.95
7-Day Total Return
-3.85%
30-Day Total Return
0.21%
60-Day Total Return
-12.36%
90-Day Total Return
-16.37%
Year to Date Total Return
-6.13%
1-Year Total Return
-47.18%
2-Year Total Return
-68.06%
3-Year Total Return
-89.87%
5-Year Total Return
-95.60%
52-week Low
Nov 25, 2025 - $2.11
52-week High
Feb 18, 2025 - $8.80
Valuation
Market Cap
$7.22M - Nano Cap
Enterprise Value
$4.96M
Price/Sales (TTM)
1.56
Price/Book (Q)
1.59
Dividends and Shares
Shares Outstanding
2.91M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.biomerica.com
Phone Number
949 645 2111
Address
17571 Von Karman Avenue
Irvine, CA 92614
Country
United States
Year Founded
1971
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical... more
NASDAQ 01/30/2026 4:00PM Eastern Quotes delayed